Narrative review / 2020
Adverse coronary heart disease events can be mitigated or avoided with lifestyle and risk factor modifications and medical therapy.
This review evaluates scientific evidence for medical therapy and revascularization in patients with stable coronary heart disease. It notes that adverse events can be mitigated or avoided through lifestyle and risk factor modifications alongside medical therapy. The authors discuss implications for patient evaluation and public policy, highlighting that revascularization is largely confined to specific high-risk subgroups.
- Study type
- State-of-the-art review
- Who was studied
- Patients with stable coronary heart disease and stable angina
- What was measured
- Evaluation, medical therapy, revascularization, and lifestyle modifications
THE PAPER
Evaluation and Management of Patients With Stable Angina: Beyond the Ischemia Paradigm: JACC State-of-the-Art Review.
Ferraro R, Latina JM, Alfaddagh A, Michos ED, Blaha MJ, Jones SR, Sharma G, Trost JC, Boden WE, Weintraub WS, Lima JAC, Blumenthal RS, Fuster V, Arbab-Zadeh A. J Am Coll Cardiol, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.